This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

Steffen Lang
President, Operations at Novartis


As President, Operations, Steffen Lang leads a team of more than 25 000 associates dedicated to manufacturing and supplying high-quality medicines to patients, and providing operational support with latest technology and business solutions to the entire Novartis enterprise. Operations at Novartis incorporates the company’s manufacturing, quality, and supply organization, as well as information technology, data and digital, procurement, environmental sustainability, facility services, and global business services.

Prior to taking on this role, Steffen was Global Head of Novartis Technical Operations (NTO). Under his leadership, NTO underwent a transformation to become one of the leading manufacturing and supply organizations in the industry, providing agile, efficient support to the business, and reliably delivering life-changing medicines to patients around the world. During this time, the unit adapted its manufacturing capacity and capabilities to the changing needs of the Novartis strategy and product portfolio, maximizing the potential of its assets and expertise. As well as delivering technological innovation to enable the production of advanced therapeutic platforms, the unit collaborated with industry partners to support global demand for COVID-19 vaccines and therapies.

Steffen draws on a wealth of experience in the pharmaceutical industry, with a career that ranges from research through development to manufacturing and supply. He joined Novartis in 1994 as Head of Laboratory in Research, and held positions of increasing responsibility before taking on his present role in 2022.

In his spare time, Steffen enjoys indoor and outdoor sports, and spending time with his family and friends.

Agenda Sessions

  • KEYNOTE: Innovation in Biopharmaceutical Manufacturing